Evidence map›Paper›PMID 12672969›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

Bioinformatic design of A-kinase anchoring protein-in silico: a potent and selective peptide antagonist of type II protein kinase A anchoring.

Neal M Alto, Scott H Soderling, Naoto Hoshi, Lorene K Langeberg, Rosa Fayos, Patricia A Jennings, John D Scott

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 162 citations in OpenAlex.

  1. Regulation of Translation by PKA Signaling Pathway.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Biochemical Analysis of AKAP-Anchored PKA Signaling Complexes.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  9. Disruptors of AKAP-Dependent Protein-Protein Interactions.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  10. Article
  11. Article
  12. AKAP Signaling Islands: Venues for Precision Pharmacology.Trends in pharmacological sciences · 2020
    Review
  13. Review
  14. Single nucleotide polymorphisms alter kinase anchoring and the subcellular targeting of A-kinase anchoring proteins.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  15. Bidirectional regulation of HDAC5 by mAKAPβ signalosomes in cardiac myocytes.Journal of molecular and cellular cardiology · 2018
    Article
  16. Role of plasma membrane-associated AKAPs for the regulation of cardiac INaunyn-Schmiedeberg's archives of pharmacology · 2017
    Article
  17. Article
  18. Review
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Neal M AltoHoward Hughes Medical Institute, Vollum Institute, Oregon Health and Science University, Portland OR 97239, USA.
Scott H Soderling
Naoto Hoshi
Lorene K Langeberg
Rosa Fayos
Patricia A Jennings
John D Scott
Vollum Institute · USOregon Health & Science University · USHoward Hughes Medical Institute · US

Funding

Project# 4: INTERACTIONS OF ANCHORING PROTEINS WITH THEIR TARGETSP01DK054441 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TAYLOR, SUSAN S. · 1999 to 2017
$27.3M
Molecular Analysis of Anchoring ProteinsR37GM048231 · NIGMS · UNIVERSITY OF WASHINGTON · PI SCOTT, JOHN D · 2004 to 2013
$2.7M
MOLECULAR ANALYSIS OF PKA-ANCHORING PROTEIN INTERACTIONR01GM048231 · NIGMS · OREGON HEALTH AND SCIENCE UNIVERSITY · PI SCOTT, JOHN D · 1992 to 2003
$858k
NIDDK NIH HHS P01 DK054441NIGMS NIH HHS GM48231NIGMS NIH HHS R01 GM048231NIGMS NIH HHS R37 GM048231PHS HHS DM54441
6 · The paper itself

Abstract

Compartmentalization of the cAMP-dependent protein kinase (PKA) is coordinated through association with A-kinase anchoring proteins (AKAPs). A defining characteristic of most AKAPs is a 14- to 18-aa sequence that binds to the regulatory subunits (RI or RII) of the kinase. Cellular delivery of peptides to these regions disrupts PKA anchoring and has been used to delineate a physiological role for AKAPs in the facilitation of certain cAMP-responsive events. Here, we describe a bioinformatic approach that yields an RII-selective peptide, called AKAP-in silico (AKAP-IS), that binds RII with a K(d) of 0.4 nM and binds RI with a K(d) of 277 nM. AKAP-IS associates with the type II PKA holoenzyme inside cells and displaces the kinase from natural anchoring sites. Electrophysiological recordings indicate that perfusion of AKAP-IS evokes a more rapid and complete attenuation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor currents than previously described anchoring inhibitor peptides. Thus, computer-based and peptide array screening approaches have generated a reagent that binds PKA with higher affinity than previously described AKAPs.

Indexed as

Amino Acid SequenceBase SequenceCell LineComputational BiologyConsensus SequenceCyclic AMP-Dependent Protein KinasesCyclic AMP-Dependent Protein Kinase Type IIDNA, ComplementaryDrug DesignHumansIn Vitro TechniquesKineticsModels, MolecularMolecular Sequence DataProtein ConformationProtein EngineeringCyclic AMP-Dependent Protein KinasesCyclic AMP-Dependent Protein Kinase Type IIDNA, ComplementaryProteinsRecombinant Proteins

Identifiers

PMID12672969
PMCPMC153575
OpenAlexW2155382589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.